{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:32:48Z","timestamp":1790728368013,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10549-013-2582-2","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T01:43:05Z","timestamp":1371260585000},"page":"863-872","source":"Crossref","is-referenced-by-count":50,"title":["A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting"],"prefix":"10.1007","volume":"139","author":[{"given":"Gary H.","family":"Lyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadie","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,16]]},"reference":[{"issue":"8","key":"2582_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM197602192940801","volume":"294","author":"G Bonadonna","year":"1976","unstructured":"Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294(8):405\u2013410. doi: 10.1056\/NEJM197602192940801","journal-title":"N Engl J Med"},{"issue":"6274","key":"2582_CR2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.282.6274.1427","volume":"282","author":"A Rossi","year":"1981","unstructured":"Rossi A, Bonadonna G, Valagussa P, Veronesi U (1981) Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J (Clin Res Ed) 282(6274):1427\u20131431","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"9814","key":"2582_CR3","first-page":"4","volume":"379","author":"EBCTCG","year":"2011","unstructured":"EBCTCG (2011) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):4\u201310","journal-title":"Lancet"},{"issue":"9","key":"2582_CR4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.1990.8.9.1483","volume":"8","author":"B Fisher","year":"1990","unstructured":"Fisher B, Brown AM, Dimitrov NV, Poisson R, Redmond C, Margolese RG, Bowman D, Wolmark N, Wickerham DL, Kardinal CG et al (1990) Two months of doxorubicin\u2013cyclophosphamide with and without interval reinduction therapy compared with 6\u00a0months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol 8(9):1483\u20131496","journal-title":"J Clin Oncol"},{"issue":"24","key":"2582_CR5","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/djh338","volume":"96","author":"B Fisher","year":"2004","unstructured":"Fisher B, Jeong JH, Anderson S, Wolmark N (2004) Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. J Natl Cancer Inst 96(24):1823\u20131831. doi: 10.1093\/jnci\/djh338","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2582_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000421-198710000-00005","volume":"10","author":"SE Jones","year":"1987","unstructured":"Jones SE, Moon TE, Bonadonna G, Valagussa P, Rivkin S, Buzdar A, Montague E, Powles T (1987) Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol 10(5):387\u2013395","journal-title":"Am J Clin Oncol"},{"issue":"9814","key":"2582_CR7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"R Peto","year":"2012","unstructured":"Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):432\u2013444. doi: 10.1016\/S0140-6736(11)61625-5","journal-title":"Lancet"},{"issue":"6","key":"2582_CR8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","volume":"21","author":"IC Henderson","year":"2003","unstructured":"Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L (2003) Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21(6):976\u2013983","journal-title":"J Clin Oncol"},{"issue":"22","key":"2582_CR9","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa043681","volume":"352","author":"M Martin","year":"2005","unstructured":"Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352(22):2302\u20132313. doi: 10.1056\/NEJMoa043681","journal-title":"N Engl J Med"},{"issue":"34","key":"2582_CR10","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","volume":"24","author":"SE Jones","year":"2006","unstructured":"Jones SE, Savin MA, Holmes FA, O\u2019Shaughnessy JA, Blum JL, Vukelja S, McIntyre KJ, Pippen JE, Bordelon JH, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Meyer WG, Asmar L (2006) Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 24(34):5381\u20135387. doi: 10.1200\/JCO.2006.06.5391","journal-title":"J Clin Oncol"},{"issue":"8","key":"2582_CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"ML Citron","year":"2003","unstructured":"Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741\/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21(8):1431\u20131439","journal-title":"J Clin Oncol"},{"issue":"9472","key":"2582_CR12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTCG","year":"2005","unstructured":"EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"17","key":"2582_CR13","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"DA Berry","year":"2005","unstructured":"Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784\u20131792. doi: 10.1056\/NEJMoa050518","journal-title":"N Engl J Med"},{"issue":"6","key":"2582_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.20134","volume":"61","author":"C DeSantis","year":"2011","unstructured":"DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):409\u2013418. doi: 10.3322\/caac.20134","journal-title":"CA Cancer J Clin"},{"key":"2582_CR15","unstructured":"American Cancer Society (2012) Cancer Facts and Figures\u00a02012"},{"issue":"4 Suppl 4","key":"2582_CR16","first-page":"3","volume":"14","author":"WM Hryniuk","year":"1987","unstructured":"Hryniuk WM, Figueredo A, Goodyear M (1987) Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol 14(4 Suppl 4):3\u201311","journal-title":"Semin Oncol"},{"issue":"16","key":"2582_CR17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jnci\/90.16.1205","volume":"90","author":"DR Budman","year":"1998","unstructured":"Budman DR, Berry DA, Cirrincione CT, Henderson IC, Wood WC, Weiss RB, Ferree CR, Muss HB, Green MR, Norton L, Frei E 3rd (1998) Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 90(16):1205\u20131211. doi: 10.1093\/jnci\/90.16.1205","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2582_CR18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-008-0018-1","volume":"114","author":"I Chirivella","year":"2009","unstructured":"Chirivella I, Bermejo B, Insa A, Perez-Fidalgo A, Magro A, Rosello S, Garcia-Garre E, Martin P, Bosch A, Lluch A (2009) Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat 114(3):479\u2013484. doi: 10.1007\/s10549-008-0018-1","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2582_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6004\/jnccn.2009.0009","volume":"7","author":"GH Lyman","year":"2009","unstructured":"Lyman GH (2009) Impact of chemotherapy dose intensity on cancer patient outcomes. J Natl Compr Cancer Netw 7(1):99\u2013108","journal-title":"J Natl Compr Cancer Netw"},{"issue":"24","key":"2582_CR20","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1200\/JCO.2003.05.002","volume":"21","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Dale DC, Crawford J (2003) Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 21(24):4524\u20134531. doi: 10.1200\/JCO.2003.05.002","journal-title":"J Clin Oncol"},{"issue":"18","key":"2582_CR21","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2011.40.1273","volume":"30","author":"SH Giordano","year":"2012","unstructured":"Giordano SH, Lin YL, Kuo YF, Hortobagyi GN, Goodwin JS (2012) Decline in the use of anthracyclines for breast cancer. J Clin Oncol 30(18):2232\u20132239. doi: 10.1200\/JCO.2011.40.1273","journal-title":"J Clin Oncol"},{"key":"2582_CR22","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. v3.2013"},{"issue":"3","key":"2582_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.critrevonc.2010.02.002","volume":"77","author":"H Wildiers","year":"2011","unstructured":"Wildiers H, Reiser M (2011) Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma. Crit Rev Oncol Hematol 77(3):221\u2013240. doi: 10.1016\/j.critrevonc.2010.02.002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"2582_CR24","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2003.09.124","volume":"21","author":"MM Kemeny","year":"2003","unstructured":"Kemeny MM, Peterson BL, Kornblith AB, Muss HB, Wheeler J, Levine E, Bartlett N, Fleming G, Cohen HJ (2003) Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21(12):2268\u20132275. doi: 10.1200\/JCO.2003.09.124","journal-title":"J Clin Oncol"},{"issue":"9","key":"2582_CR25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.293.9.1073","volume":"293","author":"HB Muss","year":"2005","unstructured":"Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293(9):1073\u20131081. doi: 10.1001\/jama.293.9.1073","journal-title":"JAMA"},{"issue":"13","key":"2582_CR26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","volume":"30","author":"JJ Griggs","year":"2012","unstructured":"Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30(13):1553\u20131561. doi: 10.1200\/JCO.2011.39.9436","journal-title":"J Clin Oncol"},{"key":"2582_CR27","doi-asserted-by":"crossref","unstructured":"(1985) Consensus conference. Adjuvant chemotherapy for breast cancer. JAMA 254(24):3461\u20133463","DOI":"10.1001\/jama.1985.03360240073038"},{"issue":"13","key":"2582_CR28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jnci\/93.13.979","volume":"93","author":"P Eifel","year":"2001","unstructured":"Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1\u20133, 2000. J Natl Cancer Inst 93(13):979\u2013989","journal-title":"J Natl Cancer Inst"},{"issue":"31","key":"2582_CR29","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2012.43.8168","volume":"30","author":"AI Neugut","year":"2012","unstructured":"Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL (2012) Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. J Clin Oncol 30(31):3800\u20133809. doi: 10.1200\/JCO.2012.43.8168","journal-title":"J Clin Oncol"},{"issue":"10","key":"2582_CR30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/cncr.24271","volume":"115","author":"Y Shen","year":"2009","unstructured":"Shen Y, Dong W, Feig BW, Ravdin P, Theriault RL, Giordano SH (2009) Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004. Cancer 115(10):2041. doi: 10.1002\/cncr.24271","journal-title":"Cancer"},{"issue":"8","key":"2582_CR31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.2008.18.4028","volume":"27","author":"S Jones","year":"2009","unstructured":"Jones S, Holmes FA, O\u2019Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer WG, Asmar L, Mackey D, Riedel S, Muss H, Savin MA (2009) Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735. J Clin Oncol 27(8):1177\u20131183","journal-title":"J Clin Oncol"},{"issue":"4","key":"2582_CR32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-010-0843-8","volume":"19","author":"A Chan","year":"2011","unstructured":"Chan A, Fu WH, Shih V, Coyuco JC, Tan SH, Ng R (2011) Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy. Support Care Cancer 19(4):497\u2013504. doi: 10.1007\/s00520-010-0843-8","journal-title":"Support Care Cancer"},{"issue":"26","key":"2582_CR33","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1200\/JCO.2009.23.0508","volume":"27","author":"D Soong","year":"2009","unstructured":"Soong D, Haj R, Leung MG, Myers R, Higgins B, Myers J, Rajagopal S (2009) High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide. J Clin Oncol 27(26):e101\u2013e102. doi: 10.1200\/JCO.2009.23.0508","journal-title":"J Clin Oncol"},{"issue":"2","key":"2582_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3747\/co.v17i2.498","volume":"17","author":"T Vandenberg","year":"2010","unstructured":"Vandenberg T, Younus J, Al-Khayyat S (2010) Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice\u2014a retrospective analysis. Curr Oncol 17(2):2\u20133","journal-title":"Curr Oncol"},{"issue":"1","key":"2582_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47(1):8\u201332. doi: 10.1016\/j.ejca.2010.10.013","journal-title":"Eur J Cancer"},{"issue":"19","key":"2582_CR36","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC (2006) 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19):3187\u20133205. doi: 10.1200\/JCO.2006.06.4451","journal-title":"J Clin Oncol"},{"key":"2582_CR37","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Myeloid Growth Factors. v1.2012"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2582-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2582-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:47:17Z","timestamp":1559220437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2582-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}